Checkpoint Therapeutics, Inc.
Total Trades
24
Buys
0
Sells
21
Largest Trade
N/A
Insiders
3
Institutional Funds
22
Inst. Value
$1M+
Activist Filings
19
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10% Owner | SELL | $100K–$500K | 100K | $1.29 | Jun 3, 2025 |
| Oliviero James F III | CEO | SELL | $50K–$100K | 15K | $4.04 | Apr 3, 2025 |
| GRAY WILLIAM GARRETT | CFO | SELL | $15K–$50K | 12K | $4.05 | Apr 3, 2025 |
| Oliviero James F III | CEO | SELL | $1M+ | 822K | $3.74 | Dec 21, 2024 |
| GRAY WILLIAM GARRETT | CFO | SELL | $1M+ | 268K | $4.01 | Dec 21, 2024 |
| Oliviero James F III | CEO | SELL | $50K–$100K | 25K | $2.05 | Jun 29, 2024 |
| GRAY WILLIAM GARRETT | CFO | SELL | $15K–$50K | 13K | $2.06 | Jun 29, 2024 |
| Oliviero James F III | CEO | SELL | $1K–$15K | 6K | $2.06 | Mar 2, 2024 |
| GRAY WILLIAM GARRETT | CFO | SELL | $1K–$15K | 2K | $2.07 | Mar 2, 2024 |
| GRAY WILLIAM GARRETT | CFO | SELL | $1K–$15K | 4K | $1.95 | Feb 3, 2024 |
| Oliviero James F III | CEO | SELL | $15K–$50K | 12K | $2.01 | Feb 3, 2024 |
| Oliviero James F III | CEO | SELL | $50K–$100K | 11K | $4.82 | Mar 4, 2023 |
| Oliviero James F III | CEO | GRANT | N/A | 15K | — | Mar 4, 2023 |
| GRAY WILLIAM GARRETT | CFO | GRANT | N/A | 8K | — | Mar 4, 2023 |
| GRAY WILLIAM GARRETT | CFO | SELL | $15K–$50K | 6K | $4.88 | Mar 4, 2023 |
| GRAY WILLIAM GARRETT | CFO | SELL | $15K–$50K | 3K | $4.79 | Feb 4, 2023 |
| Oliviero James F III | CEO | SELL | $15K–$50K | 10K | $4.77 | Feb 4, 2023 |
| GRAY WILLIAM GARRETT | CFO | SELL | $1K–$15K | 2K | $6.75 | Jan 13, 2023 |
| Oliviero James F III | CEO | SELL | $15K–$50K | 4K | $6.75 | Jan 13, 2023 |
| Oliviero James F III | CEO | SELL | $100K–$500K | 276K | $1.09 | Jul 2, 2022 |
| Oliviero James F III | CEO | SELL | $100K–$500K | 122K | $1.74 | Apr 23, 2022 |
| GRAY WILLIAM GARRETT | CFO | SELL | $50K–$100K | 38K | $1.89 | Mar 12, 2022 |
| GRAY WILLIAM GARRETT | CFO | SELL | $50K–$100K | 37K | $2.51 | Feb 3, 2022 |
| GRAY WILLIAM GARRETT | CFO | GRANT | N/A | 137K | — | Feb 3, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 22 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Squarepoint Ops LLC | 471K | $1M+ | SH |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 426K | $1M+ | SH |
| ENVESTNET ASSET MANAGEMENT INC | 64K | $100K–$500K | SH |
| ROYAL BANK OF CANADA | 60K | $100K–$500K | SH |
| PARK AVENUE SECURITIES LLC | 60K | $100K–$500K | SH |
| PVG ASSET MANAGEMENT CORP | 53K | $100K–$500K | SH |
| JONES FINANCIAL COMPANIES LLLP | 3K | $100K–$500K | SH |
| 180 WEALTH ADVISORS, LLC | 27K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 25K | $100K–$500K | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 20K | $50K–$100K | SH |
| Kovitz Investment Group Partners, LLC | 16K | $50K–$100K | SH |
| Cannon Global Investment Management, LLC | 10K | $15K–$50K | SH |
| Keudell/Morrison Wealth Management | 10K | $15K–$50K | SH |
| PUREfi Wealth, LLC | 10K | $15K–$50K | SH |
| ARK & TLK INVESTMENTS, LLC | 10K | $15K–$50K | SH |
| FNY Investment Advisers, LLC | 10K | $15K–$50K | SH |
| AMERIFLEX GROUP, INC. | 9K | $15K–$50K | SH |
| BlackRock, Inc. | 6K | $15K–$50K | SH |
| Cordant, Inc. | 2K | $1K–$15K | SH |
| JONES FINANCIAL COMPANIES LLLP | 1K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13D/A · Jun 3, 2025
0.0%
0 shares
SC 13G/A · May 15, 2025
3.8%
3.2M shares
SC 13G/A · May 15, 2025
5.0%
4.4M shares
SC 13G · Mar 17, 2025
9.9%
6.1M shares
SC 13G · Mar 17, 2025
6.4%
3.1M shares
SC 13D/A · Mar 11, 2025
11.2%
6.9M shares
SC 13G/A · Feb 14, 2025
10.0%
5.2M shares
SC 13D/A · Jan 3, 2025
13.5%
6.9M shares
SC 13G/A · Nov 14, 2024
10.0%
4.6M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Oct 1, 2024
9.8%
4.4M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · May 17, 2024
11.2%
4.3M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Mar 22, 2024
7.5%
2.8M shares
SC 13G/A · Feb 14, 2024
10.0%
2.7M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Sep 26, 2023
11.3%
2.4M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Jul 6, 2023
13.6%
2.4M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Apr 19, 2023
17.5%
2.3M shares
SC 13G · Feb 14, 2023
10.0%
987K shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Jan 13, 2023
19.3%
2.2M shares